Home  »  Hot Stocks   »  Kezar Life Sciences Inc. (KZR) Shares Decline Desp...

Kezar Life Sciences Inc. (KZR) Shares Decline Despite Market Challenges

Kezar Life Sciences Inc. (NASDAQ: KZR)’s stock price has dropped by -6.62 in relation to previous closing price of 3.02.

Is It Worth Investing in Kezar Life Sciences Inc. (NASDAQ: KZR) Right Now?

while the 36-month beta value is 0.15.Analysts have differing opinions on the stock, with 5 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”

25-cent Stock Takes $11T Commodities Sector Digital

One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.

All the details are in the FREE online report you can get here.


The average price point forecasted by analysts for Kezar Life Sciences Inc. (KZR) is $15.67, which is $12.68 above the current market price. The public float for KZR is 54.06M, and currently, short sellers hold a 6.37% ratio of that floaft. The average trading volume of KZR on May 25, 2023 was 1.06M shares.

KZR’s Market Performance

KZR’s stock has seen a 0.00% decrease for the week, with a 15.10% rise in the past month and a -55.38% fall in the past quarter. The volatility ratio for the week is 7.98%, and the volatility levels for the past 30 days are at 7.24% for Kezar Life Sciences Inc. The simple moving average for the past 20 days is 5.34% for KZR’s stock, with a -56.36% simple moving average for the past 200 days.

KZR Trading at -2.56% from the 50-Day Moving Average

After a stumble in the market that brought KZR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -74.41% of loss for the given period.

Volatility was left at 7.24%, however, over the last 30 days, the volatility rate increased by 7.98%, as shares surge +18.99% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -45.56% lower at present.

During the last 5 trading sessions, KZR remain unchanged, which changed the moving average for the period of 200-days by -73.12% in comparison to the 20-day moving average, which settled at $2.70. In addition, Kezar Life Sciences Inc. saw -59.94% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at KZR starting from Morningside Venture Investment, who sale 40,000 shares at the price of $6.88 back on Feb 06. After this action, Morningside Venture Investment now owns 5,447,993 shares of Kezar Life Sciences Inc., valued at $275,320 using the latest closing price.

Morningside Venture Investment, the 10% Owner of Kezar Life Sciences Inc., sale 25,000 shares at $7.15 during a trade that took place back on Feb 03, which means that Morningside Venture Investment is holding 5,487,993 shares at $178,650 based on the most recent closing price.

Stock Fundamentals for KZR

The total capital return value is set at -28.38, while invested capital returns managed to touch -27.39. Equity return is now at value -27.00, with -24.70 for asset returns.

Based on Kezar Life Sciences Inc. (KZR), the company’s capital structure generated 7.88 points at debt to equity in total, while total debt to capital is 7.30. Total debt to assets is 7.10, with long-term debt to equity ratio resting at 6.93. Finally, the long-term debt to capital ratio is 6.42.

The liquidity ratio also appears to be rather interesting for investors as it stands at 25.98.


In a nutshell, Kezar Life Sciences Inc. (KZR) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.